Literature DB >> 15822070

High-resolution multi-parameter DNA flow cytometry enables detection of tumour and stromal cell subpopulations in paraffin-embedded tissues.

Willem E Corver1, Natalja T Ter Haar, Enno J Dreef, Noel F C C Miranda, Frans A Prins, Ekaterina S Jordanova, Cees J Cornelisse, Gert Jan Fleuren.   

Abstract

The accuracy of DNA ploidy measurements of paraffin-embedded tissues is limited by the lack of resolution and the inability to identify the DNA diploid population unequivocally in bimodal DNA histograms. A multi-parameter DNA flow cytometric method has been developed that enables the simultaneous detection of neoplastic and stromal cells in samples from dewaxed 50 microm sections or 2 mm diameter punches of archival tissue blocks. The method combines heat pretreatment in sodium citrate buffer and subsequent enzymatic dissociation with a collagenase/dispase mixture. Cells were simultaneously stained for keratin (FITC), vimentin (R-PE), and DNA (PI) before flow cytometric analysis. The method was applied to 12 paraffin-embedded cervical carcinomas and four colorectal carcinomas. In all cervical cancers, distinct keratin-positive and vimentin-positive cell populations were observed. While the exclusive vimentin-positive cell fractions always yielded unimodal DNA content distributions, bimodal distributions were observed for the keratin-positive cell fractions in nine cervical carcinomas, whereas one cervical carcinoma showed three distinct G0G1 populations. Coefficients of variation of the G0G1 peaks ranged from 1.70% to 4.79%. Average background, aggregate, and debris values were 14.7% (vimentin-positive fraction) and 33.8% (keratin-positive fraction). Flow sorting confirmed that the exclusively vimentin-positive cell fractions represent different normal stromal and infiltrate cells that can serve as an internal ploidy reference enabling discrimination between DNA hypo-diploid and DNA hyper-diploid tumour cell subpopulations. The neoplastic origin of the keratin-vimentin co-expressing cells from two cervical carcinomas was confirmed by genotyping of flow-sorted samples revealing loss of heterozygosity (LOH) of 6p. This improved method obviates the need for fresh/frozen tumour tissue for high-resolution DNA ploidy measurements and enables the isolation of highly purified tumour subpopulations for subsequent genotyping. Copyright 2005 Pathological Society of Great Britain and Ireland

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15822070     DOI: 10.1002/path.1765

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  14 in total

1.  Mass spectrometry-based loss of heterozygosity analysis of single-nucleotide polymorphism loci in paraffin embedded tumors using the MassEXTEND assay: single-nucleotide polymorphism loss of heterozygosity analysis of the protein tyrosine phosphatase receptor type J in familial colorectal cancer.

Authors:  Marjo van Puijenbroek; Jan Willem F Dierssen; Patrick Stanssens; Ronald van Eijk; Anne Marie Cleton-Jansen; Tom van Wezel; Hans Morreau
Journal:  J Mol Diagn       Date:  2005-11       Impact factor: 5.568

2.  Proper genomic profiling of (BRCA1-mutated) basal-like breast carcinomas requires prior removal of tumor infiltrating lymphocytes.

Authors:  Maarten P G Massink; Irsan E Kooi; Saskia E van Mil; Ekaterina S Jordanova; Najim Ameziane; Josephine C Dorsman; Daphne M van Beek; J Patrick van der Voorn; Daoud Sie; Bauke Ylstra; Carolien H M van Deurzen; John W Martens; Marcel Smid; Anieta M Sieuwerts; Vanja de Weerd; John A Foekens; Ans M W van den Ouweland; Ewald van Dyk; Petra M Nederlof; Quinten Waisfisz; Hanne Meijers-Heijboer
Journal:  Mol Oncol       Date:  2015-01-13       Impact factor: 6.603

3.  Detection of genetic alterations by immunoFISH analysis of whole cells extracted from routine biopsy material.

Authors:  Göran Mattsson; Soo Yong Tan; David J P Ferguson; Wendy Erber; Susan H Turner; Teresa Marafioti; David Y Mason
Journal:  J Mol Diagn       Date:  2007-08-09       Impact factor: 5.568

4.  Multiparameter DNA content analysis identifies distinct groups in primary breast cancer.

Authors:  J H S Dayal; M J Sales; W E Corver; C A Purdie; L B Jordan; P R Quinlan; L Baker; N T ter Haar; N R Pratt; A M Thompson
Journal:  Br J Cancer       Date:  2013-02-14       Impact factor: 7.640

5.  Cervical carcinoma-associated fibroblasts are DNA diploid and do not show evidence for somatic genetic alterations.

Authors:  Willem Ernst Corver; Natalja Tatjana Ter Haar; Gert Jan Fleuren; Jan Oosting
Journal:  Cell Oncol (Dordr)       Date:  2011-11-01       Impact factor: 6.730

6.  Genome haploidisation with chromosome 7 retention in oncocytic follicular thyroid carcinoma.

Authors:  Willem E Corver; Dina Ruano; Karin Weijers; Wietske C E den Hartog; Merlijn P van Nieuwenhuizen; Noel de Miranda; Ronald van Eijk; Anneke Middeldorp; Ekaterina S Jordanova; Jan Oosting; Ellen Kapiteijn; Guido Hovens; Jan Smit; Tom van Wezel; Hans Morreau
Journal:  PLoS One       Date:  2012-06-01       Impact factor: 3.240

7.  HNPCC versus sporadic microsatellite-unstable colon cancers follow different routes toward loss of HLA class I expression.

Authors:  Jan Willem F Dierssen; Noel F C C de Miranda; Soldano Ferrone; Marjo van Puijenbroek; Cees J Cornelisse; Gert Jan Fleuren; Tom van Wezel; Hans Morreau
Journal:  BMC Cancer       Date:  2007-02-22       Impact factor: 4.430

8.  Combined array-comparative genomic hybridization and single-nucleotide polymorphism-loss of heterozygosity analysis reveals complex genetic alterations in cervical cancer.

Authors:  Judith N Kloth; Jan Oosting; Tom van Wezel; Karoly Szuhai; Jeroen Knijnenburg; Arko Gorter; Gemma G Kenter; Gert Jan Fleuren; Ekaterina S Jordanova
Journal:  BMC Genomics       Date:  2007-02-20       Impact factor: 3.969

9.  Integral analysis of p53 and its value as prognostic factor in sporadic colon cancer.

Authors:  Arantza Fariña Sarasqueta; Giusi Forte; Wim E Corver; Noel F de Miranda; Dina Ruano; Ronald van Eijk; Jan Oosting; Rob A E M Tollenaar; Tom van Wezel; Hans Morreau
Journal:  BMC Cancer       Date:  2013-06-05       Impact factor: 4.430

10.  Contribution of multiparameter flow cytometry immunophenotyping to the diagnostic screening and classification of pediatric cancer.

Authors:  Cristiane S Ferreira-Facio; Cristiane Milito; Vitor Botafogo; Marcela Fontana; Leandro S Thiago; Elen Oliveira; Ariovaldo S da Rocha-Filho; Fernando Werneck; Danielle N Forny; Samuel Dekermacher; Ana Paula de Azambuja; Sima Esther Ferman; Paulo Antônio Silvestre de Faria; Marcelo G P Land; Alberto Orfao; Elaine S Costa
Journal:  PLoS One       Date:  2013-03-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.